| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Net loss | -22,144 | -25,949 | ||
| Net loss per share, basic | -0.41 | -0.49 | ||
| Net loss per share, diluted | -0.41 | -0.49 | ||
| Weighted-average shares of common stock used to compute net loss per share, basic | 53,577,066 | 53,445,631 | ||
| Weighted-average shares of common stock used to compute net loss per share, diluted | 53,577,066 | 53,445,631 | ||
ALX ONCOLOGY HOLDINGS INC (ALXO)
ALX ONCOLOGY HOLDINGS INC (ALXO)